A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
Clinical trial NCT02952248 · COMPLETED
Trial details
- NCT number
- NCT02952248
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-21
- Primary completion
- 2021-04-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.